Skip to content

Postpartum pElvic Assisted Recovery With Leva

Feasibility of Pelvic Floor Muscle Training With a Digital Therapeutic Motion-based Device (Leva Device) in a Postpartum Population

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06609317
Acronym
PEARL
Enrollment
25
Registered
2024-09-24
Start date
2025-04-04
Completion date
2026-02-28
Last updated
2025-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Pelvic Floor Function and Symptoms

Keywords

postpartum pelvic muscle training, postpartum pelvic floor, postpartum pelvic floor physical therapy, postpartum urinary incontinence, postpartum bowel incontinence, postpartum pelvic floor recovery

Brief summary

The goal of this prospective cohort study is to evaluate the feasibility of postpartum pelvic floor muscle training using an FDA-cleared digital therapeutic motion-based device. In addition to assessing feasibility, investigators also will evaluate bladder and bowel function, pelvic organ prolapse symptoms, and vaginal and perineal pain in the immediate postpartum period and at 3 and 6 months postpartum. Investigators also will assess sexual function at 3 and 6 months postpartum. Participants will use the motion-based device for postpartum pelvic floor muscle training and will complete electronically administered surveys at 3 and 6 months postpartum.

Interventions

DEVICEDigital therapeutic motion-based device

This intervention includes use of a digital therapeutic motion-based device for pelvic floor muscle training

Sponsors

University of South Florida
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Spontaneous vaginal delivery within the last 4-8 weeks * Age ≥ 18 years * Ambulatory * Willing and able to consent to participate. * English speaking * Owns a smartphone

Exclusion criteria

* Operative or cesarean delivery * Obstetric delivery at less than 20 weeks gestation * Third- or fourth-degree perineal laceration * Episiotomy * Multiples

Design outcomes

Primary

MeasureTime frameDescription
FeasibilityFrom enrollment to 6 months postpartumFeasibility will be assessed using participant reported discomfort with device use, ease of device use, net promotor score, patient satisfaction, and free text feedback on the device.
Perineal PainFrom enrollment to 6 months postpartumParticipants will complete validated surveys assessing perineal pain at baseline, 3 months postpartum, and 6 months postpartum.

Secondary

MeasureTime frameDescription
Pelvic Organ ProlapseFrom enrollment to 6 months postpartumParticipants will complete validated surveys assessing pelvic organ prolapse symptoms at baseline, 3 months postpartum, and 6 months postpartum.
Bladder functionFrom enrollment to 6 months postpartumParticipants will complete validated surveys assessing bladder function at baseline, 3 months postpartum, and 6 months postpartum.
Sexual functionFrom enrollment to 6 months postpartumParticipants will complete validated surveys assessing sexual function at 3 months postpartum and 6 months postpartum.
Vaginal painFrom enrollment to 6 months postpartumParticipants will complete validated surveys assessing vaginal pain at baseline, 3 months postpartum, and 6 months postpartum.
Bowel FunctionFrom enrollment to 6 months postpartumParticipants will complete validated surveys assessing bowel function at baseline, 3 months postpartum, and 6 months postpartum.

Countries

United States

Contacts

Primary ContactKatie Propst, MD
katiepropst@usf.edu813-259-0655
Backup ContactMaha Al Jumaily, MBBS
mahaaljumaily@usf.edu813-259-8680

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026